Direct-to-Consumer (DTC) Genetic Testing

Direct-to-Consumer (DTC) Genetic Testing

Global Direct-to-Consumer (DTC) Genetic Testing Market to Reach US$3.4 Billion by 2030

The global market for Direct-to-Consumer (DTC) Genetic Testing estimated at US$1.3 Billion in the year 2023, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Single Nucleotide Polymorphism (SNP) Chips Technology, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Targeted Analysis Technology segment is estimated at 15.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$535.4 Million While China is Forecast to Grow at 16.9% CAGR

The Direct-to-Consumer (DTC) Genetic Testing market in the U.S. is estimated at US$535.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$269.8 Million by the year 2030 trailing a CAGR of 16.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.8% and 15.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.

Global Direct-to-Consumer (DTC) Genetic Testing Market - Key Trends and Drivers Summarized

Direct-to-Consumer (DTC) genetic testing refers to genetic tests that are marketed directly to consumers without the need for an intermediary healthcare provider. These tests offer individuals insights into their genetic predispositions for a variety of issues, including risks for certain diseases, information about ancestry, and traits affecting wellness and nutrition. Consumers can purchase these tests online, collect a DNA sample using a kit typically involving saliva or a cheek swab, and send it back to the company for analysis. Results are usually accessed via a secure online account, providing detailed reports that explain the genetic findings and their potential implications. This model of genetic testing is aimed at increasing accessibility to genetic information and empowering consumers with knowledge about their health and heritage.

The DTC genetic testing market has expanded rapidly due to technological advances in genomics and a significant reduction in the cost of DNA analysis. Innovations in genetic sequencing technology and data analytics have made it possible for companies to offer these tests at a consumer-friendly price while ensuring a quick turnaround for results. The scope of tests has also broadened, with companies offering panels that can assess risk for hundreds of conditions or provide detailed genealogical histories. This accessibility invites consumers who are curious about their genetic makeup to explore their ancestry, understand their predisposition to certain health conditions, respond better to particular medications, or tailor their diet and lifestyle based on their genetic markers. As consumer awareness and interest grow, the demand for these personalized insights increases, pushing the market forward.

The growth in the DTC genetic testing market is driven by several factors. A key driver is the increasing consumer interest in personalized health and wellness. As people become more proactive about their health, they seek detailed information that could guide their lifestyle choices and medical decisions. Technological advancements that enhance the accuracy and depth of genetic analysis further stimulate market growth. Moreover, the growing trend of preventive healthcare and the potential of genetic testing to contribute to early disease detection and management attract more consumers. Regulatory developments also play a significant role, as clearer guidelines and approvals from bodies like the FDA boost consumer confidence in the validity and reliability of these tests. Additionally, marketing strategies that emphasize the empowerment of individuals to manage their health independently resonate strongly with modern healthcare consumers, who are increasingly inclined to take control of their health data and choices. As a result, the DTC genetic testing market continues to expand, driven by both technological innovation and evolving consumer behavior.

Select Competitors (Total 81 Featured) -

• Ambry Genetics
• 23andMe, Inc.
• Ancestry.com LLC
• Any Lab Test Now
• Color Genomics, Inc.
• Direct Laboratory Services LLC (DirectLabs)
• DNA Diagnostics Center
• Anglia DNA Services
• Centrillion Technologies, Inc.,
• Dante Labs, Inc.
• Asper Biogene LLC
• Bou Trade Labs, S.L (24 genetics )
• African Ancestry, Inc.
• Chengdu 23Mofang Biotechnology Co., Ltd.
• Atlas Biomed Group Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.